1,051
Views
44
CrossRef citations to date
0
Altmetric
Technology Evaluation

Monitoring Gq-coupled receptor response through inositol phosphate quantification with the IP-One assay

, &
Pages 981-994 | Published online: 08 Sep 2011

Bibliography

  • Pierce KL, Premont RT, Lefkowitz RJ. Seven-transmembrane receptors. Nat Mol Cell Biol 2002;3:639-50
  • Fredriksson R, Lagerstrom MC, Lundin LG, The G-Protein-Coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and Fingerprints. Mol Pharm 2003;63:1256-72
  • Hamm HE. The Many faces of G protein signaling. J Biol Chem 1998;273:669-72
  • Leifert WR, Aloia AL, Bucco O, GPCR-induced dissociation of G-protein subunits in early stage signal transduction. Mol Membr Biol 2005;22:507-17
  • Hermans E. Biochemical and pharmacological control of the multiplicity of coupling at G-protein-coupled receptors. Pharmacol Ther 2003;99:25-44
  • Offermanns S. G-proteins as transducers in transmembrane signalling. Prog Biophys Mol Biol 2003;83:101-30
  • Bimbaumer L, Bimbaumer M. Minireview: Signal transduction by G proteins: 1994 edition. J Recept Signal Transduct Res 1995;15:213-52
  • Cabrera-Vera TM, Vanhauwe J, Thomas TO, Insights into G protein structure, function, and regulation. Endocr Rev 2003;24:765-81
  • Pierce KL, Luttrell LM, Lefkowitz RJ. New mechanisms in heptahelical receptor signalling to mitogen activated protein kinase cascades. Oncogene 2001;20:1532-9
  • Wetzker R, Bohmer FD. Transactivation joins multiple tracks to the ERK/MAPK cascade. Nat Rev Mol Cell Biol 2003;4:651-7
  • Pierce KL, Lefkowitz RJ. Classical and new roles of [beta]-arrestins in the regulation of G-protein coupled receptors. Nat Rev Neurosci 2001;2:727-33
  • Xiao K, Sun J, Kim J, Global phosphorylation analysis of beta-arrestin-mediated signalling downstream of a seven transmembrane receptor (7TMR). PNAS 2010;107:15299-304
  • Lefkowitz RJ, Shenoy SK. Tranduction of receptor signals by beta-arrestins. Science 2005;308:512-17
  • Siehler S. Cell-based assays in GPCR drug discovery. Biotechnol J 2008;3:471-83
  • McLoughlin D, Bertelli F, Williams C. The A, B, Cs of G-protein-coupled receptor pharmacology in assay development for HTS. Expert Opin Drug Discov 2007;2:603-19
  • Kenakin T. G protein coupled receptors as allosteric proteins and the role of allosteric modulators. J Recept Signal Transduct Res 2010;30:313-21
  • Pin J-P, Kniazeff J, Liu J, Allosteric functioning of dimeric class C G-protein-coupled receptors. FEBS J 2005;272:2947-55
  • Handl HL, Gillies RJ. Lanthanide-based luminescent assays for ligand-receptor interactions. Life Sci 2005;77:361-71
  • Zwier JM, Roux T, Cottet M, A fluorescent ligand-binding alternative using tag-lite technology. J Biomol Screen 2010;15:1248-59
  • Chung S, Funakoshi T, Civelli O. Orphan GPCR research. Br J Pharmacol 2008;153:S339-46
  • Bond RA, Ijzerman AP. Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery. Trends Pharmacol Sci 2006;27:92-6
  • Chen G, Way J, Armour S, Use of constitutive G protein-coupled receptor activity for drug discovery. Mol Pharm 2000;57:125-34
  • Gabriel D, Vernier M, Pfeifer MJ, High throughput screening technologies for direct cyclic AMP measurement. Assay Drug Dev Technol 2003;1:291-303
  • Williams C. cAMP detection methods in HTS: selecting the best from the rest. Nat Rev Drug Discov 2004;3:125-35
  • Chambers C, Smith F, Williams C, Measuring intracellular calcium fluxes in high throughput mode. Comb Chem High Throughput Screen 2003;6:355-62
  • Hill SJ, Baker JG, Rees S. Reporter-gene systems for the study of G-protein-coupled receptors. Curr Opin Pharmacol 2001;1:526-32
  • Ferrer M, Kolodin GD, Zuck P, A fully automated [35S]GTPgammaS scintillation proximity assay for the high throughput screening of Gi-linked G protein-coupled receptors. Assay Drug Dev Technol 2003;1:261-73
  • Gales C, Rebois RV, Hogue M, Real-time monitoring of receptor and G-protein interactions in living cells. Nat Methods 2005;2:163-4
  • Ayoub MA, Pfleger KD. Recent advances in bioluminescence resonance energy transfer technologies to study GPCR heterodimerization. Curr Opin Pharmacol 2010;10:44-52
  • Siehler S. Regulation of RhoGEF proteins by G12/13-coupled receptors. Br J Pharmacol 2009;158:41-9
  • Middleton RJ, Kellam B. Fluorophore-tagged GPCR ligands. Curr Opin Chem Biol Mech 2005;9:517-25
  • Adie EJ, Francis MJ, Davies J, CypHer 5: a generic approach for measuring the activation and trafficking of G protein-coupled receptors in live cells. Assay Drug Dev Technol 2003;1:251-9
  • McGuinness D, Malikzay A, Visconti R, Characterizing cannabinoid 2 receptor ligands using discoveRx PathHunter beta-Arrestin assay. J Biomol Screen 2009;14:49-58
  • See HB, Seeber RM, Kocan M, Application of G protein-coupled receptor-heteromer identification technology to monitor beta-arrestin recruitment to G protein-coupled receptor heteromers. Assay Drug Dev Technol 2011;9:21-30
  • Leifert WR, Aloia AL, Bucco O, G-Protein-coupled receptors in drug discovery: nanosizing using cell-free technologies and molecular biology approaches. J Biomol Screen 2005;10:765-79
  • Osmond RIW, Sheehan A, Borowicz R, GPCR Screening via ERK 1/2: a novel platform for screening G Protein-coupled receptors. J Biomol Screen 2005;10:730-7
  • Challis RAJ, Batty IH, Nahorski SR. Mass measurements of inositol (1,4,5) triphosphate in rat cerebral cortex slices using a radioreceptor assay: effect of neurotransmitters and depolarization. Biochem Biophys Res Commun 1988;157:684-91
  • Berridge MJ. Inositol trisphosphate and calcium signalling. Nature 1993;361:315-25
  • Irvine RF, Letcher AJ, Heslop JP, The inositol tris/tetrakisphosphate pathway demonstration of Ins(l,4,5)P3 3-kinase activity in animal tissues. Nature 1986;320:631-4
  • Pattni K, Banting G. Ins(1,4,5)P3 metabolism and the family of IP3-3Kinases. Cell Signal 2004;16:643-54
  • Irvine RF, Schell MJ. Back in the water: the return of the inositol phosphates. Nat Rev Mol Cell Biol 2001;2:327-38
  • Majerus PW, Kisseleva MV, Norris FA. The Role of Phosphatases in Inositol Signaling Reactions. J Biol Chem 1999;274:10669-72
  • Atack JR, Broughton HB, Pollack SJ. Structure and mechanism of inositol monophosphatase. FEBS Lett 1995;361:1-7
  • Parthasarathy L, Vadnal RE, Parthasarathy R, Biochemical and molecular properties of lithium-sensitive myo-inositol monophosphatase. Life Sci 1994;54:1127-42
  • Inhorn RC, Majerus PW. Inositol polyphosphate 1-phosphatase from calf brain. Purification and inhibition by Li+, Ca2+, and Mn2+. J Biol Chem 1987;262:15946-52
  • Inhorn RC, Majerus PW. Properties of inositol polyphosphate 1-phosphatase. J Biol Chem 1988;263:14559-65
  • Berridge MJ, Dawson RM, Downes CP, Changes in the levels of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides. Biochem J 1983;212:473-82
  • Brandish PE, Hill LA, Zheng W, Scintillation proximity assay of inositol phosphates in cell extracts: high-throughput measurement of G-protein-coupled receptor activation. Anal Biochem 2003;313:311-18
  • Liu JJ, Hartman DS, Bostwick JR. An immobilized metal ion affinity adsorption and scintillation proximity assay for receptor-stimulated phosphoinositide hydrolysis. Anal Biochem 2003;318:91-9
  • Chelsky D, Bosse R, Illy C. Alphascreen HTS assay for IP3. [abstract 10058] 7th SBS annual conference and exhibition, Baltimore 2001 sept. 10-13
  • Eglen RM, Reisine T, Roby P, The use of alphascreen technology in HTS: current status. Curr Chem Genet 2008;1:2-10
  • Rowlins P, Dale I, Coldwell M. A Comparison of fluorescence polarisation and alphascreen assays for the measurement of intracellular Inositol 1,4,5-trisphosphate. Available from: http://las.perkinelmer.com/Content/relatedmaterials/posters/pst_comparisonfluopolaralphascreenassays.pdf
  • Eglen RM. Functional G protein-coupled receptor assays for primary and secondary screening. Comb Chem High Throughput Screen 2005;8:311-18
  • Neilsen PO, Assis EF, Angie M, HT non radiaoctive inositol phosphate assay for GPCR inhibitor screening. Poster #P08064. 9th SBS annual conference and exhibition, Portland. 2003 sept. 21-25
  • Trinquet E, Fink M, Bazin H, d-myo-Inositol 1-phosphate as a surrogate of d-myo-inositol 1,4,5-tris phosphate to monitor G protein-coupled receptor activation. Anal Biochem 2006;358:126-35
  • Bergsdorf C, Kropp-Goerkis C, Kaehler I, A one-day, dispense-only IP-one HTRF assay for high-throughput screening of Gq protein-coupled receptors: towards cells as reagents. Assay Drug Dev Technol 2008;6:39-53
  • Ayoub MA, Maurel D, Binet V, Real-time analysis of agonist-induced activation of protease-activated receptor 1/Galphai1 protein complex measured by bioluminescence resonance energy transfer in living cells. Mol Pharm 2007;71:1329-40
  • Kemp EH, Gavalas NG, Krohn KJE, Activating autoantibodies against the calcium-sensing receptor detected in two patients with autoimmune polyendocrine syndrome type 1. J Clin Endocrinol Metab 2009;94:4749-56
  • Hrovat A, Zavec A, Pogacnik A, Establishing and functional characterization of an HEK-293 cell line expressing autofluorescently tagged beta-actin (pEYFP-ACTIN) and the neurokinin type 1 receptor (NK1-R). Cell Mol Biol Lett 2010;15:55-69
  • Trinquet E, Gregor N, Lamarque L, Introduction of a new TR-FRET terbium cryptate. Application to IP-One Tb, a new generation of HTRF kit for GPCR screening & investigation. 14th SBS annual conference and exhibition, St Louis 2008. Available from: http://www.htrf.com/files/resources/poster_ip-one-tb_sbs_08_ss-coupe.pdf
  • Ma L, Seager MA, Wittmann M, Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation. PNAS 2009;106:15950-5
  • Graf M. Two GPCR case studies with the IP-One Eu and Tb assay kits. A positive modulator and an inverse agonist project. 14th SBS annual conference and exhibition, St Louis 2008. Available from: http://www.htrf.com/files/resources/IPone%20Talk%20SBS%202008%20(Roche).pdf
  • Liu T, Titus S, Southall N, Comparison on functional assays for Gq-coupled GPCRs by measuring inositol monophospate-1 and intracellular calcium in 1536-well plate format. Curr Chem Genomics 2008;1:70-8
  • Cassutt KJ, Orsini MJ, Abousleiman M, Identifying nonselective hits from a homogeneous calcium assay screen. J Biomol Screen 2007;12:285-7
  • Milligan G, Rees S. Chimaeric G[alpha] proteins: their potential use in drug discovery. Trends Pharm Sci 1999;20:118-24
  • Bouhelal R. Use of the IP-one HTRF assay for HTS and secondary screening of Gq and Galpha16 coupled receptor targets. HTRF® 3rd Annual Symposium, Sonoma CA, September 26th-28th, 2007. Available from: http://www.htrf.com/files/resources/Abstract_symposium2007_Bouhelal%20.pdf
  • Kostenis E. G proteins in drug screening: from analysis of receptor G-protein specificity to manipulation of GPCR-mediated signalling pathways. Curr Pharm Des 2006;12:1703-15
  • Zhang JY, Kowal DM, Nawoschik SP, Development of an improved IP1 assay for the characterization of 5-HT2C receptor ligands. Assay Drug Dev Technol 2009;7:1-8
  • Gee KR, Brown KA, Chen WN, Chemical and physiological characterization of fluo-4 Ca2+-indicator dyes. Cell Calcium 2000;27:97-106
  • Minta A, Kao JP, Tsien RY. Fluorescent indicators for cytosolic calcium based on rhodamine and fluorescein chromophores. J Biol Chem 1989;264:8171-8
  • Lepoul E, Hisada S, Mizuguchi Y, Adaptation of Aequorin functional assay to high throughput screening. J Biomol Screen 2002;7:57-65
  • Bouhelal R. Novel functional approaches for GPCR ligand discovery. Screening Europe, Barcelona 2007. Available from: http://www.htrf.com/files/resources/Rochdi.Bouhelal.2007.IP-One.pdf
  • Peters MF, Knappenberger KS, Wilkins D, Evaluation of cellular dielectric spectroscopy, a whole-cell, label-free technology for drug discovery on gi-coupled GPCRs. J Biomol Screen 2007;12:312-19
  • Bercher M, Hanson B, Van Staden C, Agonists of the orphan human G2A receptor identified from inducible G2A expression and beta-lactamase reporter screen. Assay Drug Dev Technol 2009;7:133-42
  • Dietz M, Lacoste C, Christensen K, High throughput hit profiling with the HTRF IP-One Terbium kit to determine agonists, inverse agonists and antagonists. MIPTEC, Basel 2009. Available from: http://www.htrf.com/files/resources/ip-one_poster_Roche_miptec2009.pdf
  • Bazin H, Trinquet E, Mathis G. Time resolved amplification of cryptate emission: a versatile technology to trace biomolecular interactions. Rev Mol Biotech 2002;82:233-50
  • Trinquet E, Mathis G. Fluorescence technologies for the investigation of chemical libraries. Mol Biosyst 2006;2:380-7
  • Galandrin S, Oligny-Longpre G, Bouvier M. The evasive nature of drug efficacy: implications for drug discovery. Trends Pharm Sci Spec Issue Allosterism Collateral Efficacy 2007;28:423-30
  • Wei H, Ahn S, Shenoy SK, Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2. PNAS 2003;100:10782-7
  • Galandrin S, Oligny-Longpre G, Bonin H, Conformational rearrangements and signaling cascades involved in ligand-biased mitogen-activated protein kinase signaling through the beta-Adrenergic Receptor. Mol Pharm 2008;74:162-72
  • Sohy D, Parmentier M, Springael JY. Allosteric transinhibition by specific antagonists in CCR2/CXCR4 heterodimers. J Biol Chem 2007;282:30062-9
  • Gonzales-Maeso J, Ang RL, Yuen T, Identification of a serotonin/glutamate receptor complex implication in psychosis. Nature 2008;452:93-7
  • Lee SP, So CH, Rashid AJ, Dopamine D1 and D2 receptor co-activation generates a novel phospholipase C-mediated calcium signal. J Biol Chem 2004;279:35671-8
  • Pei L, Li S, Wang M, Uncoupling the D1-D2 receptor complex exerts antidepressant-like effects. Nat Med 2010;16:1393-5
  • Rashid AJ, So CH, Kong MM, D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum. PNAS 2007;104:654-9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.